✦ LIBER ✦

A randomized controlled clinical trial of recombinant interferon α-2b in the treatment of acute post-transfusion hepatitis C: A preliminary report

✍ Scribed by S-J. HWANG; S-D. LEE; Y-H. W. LEE; J-C. WU; C-Y. CHAN; Y-S. HUANG; Y-J. WANG; K-J. LO

Book ID: 118704332
Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 620 KB
Volume: 8
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.1993.tb01691.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled trial of recombi

A randomized controlled trial of recombinant interferon α-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C

✍ Shinn-Jang Hwang; Shou-Dong Lee; Cho-Yu Chan; Rei-Hwa Lu; Kwang-Juei Lo 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 538 KB

A multicenter randomized controlled tria

A multicenter randomized controlled trial of recombinant interferon-α2b in patients with acute transfusion-associated hepatitis C

✍ Pietro Lampertico; Mariagrazia Rumi; Raffaella Romeo; Antonio Craxi; Roberta Sof 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 1 views

Treatment of chronic hepatitis C with re

Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trial

✍ Giulio Diodati; Paola Bonetti; Franco Noventa; Carla Casarin; Massimo Rugge; Ser 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Sixty consecutive patients with chronic hepatitis C were included in a randomized controlled trial of recombinant human interferon-%, vs. no treatment. Treated patients received tapering doses of interferon thrice weekly for 1 yr. Twenty treated cases (66.7%) normalized serum aminotransferase levels

Combined interferon α2b and cyclosporin

Combined interferon α2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial

✍ Kazuaki Inoue, Kazuhiko Sekiyama, Masaya Yamada, Tsunamasa Watanabe, Hiroshi Yas 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 165 KB

Recombinant interferon-α-2a for treatmen

Recombinant interferon-α-2a for treatment of chronic hepatitis C: results of a multicenter randomized controlled dose study

✍ Y. Imai; S. Kawata; S. Tamura; N. Ito; K. Seki; M. Nishiuchi; Y. Shinji; K. Kiri 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

Treatment of hepatitis C virus–related c

Treatment of hepatitis C virus–related cirrhosis: A randomized, controlled trial of interferon alfa-2b versus no treatment

✍ Dominique-Charles Valla; Michele Chevallier; Patrick Marcellin; Jean-Louis Payen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

To examine the effects of interferon (IFN) therapy on clinical, biochemical, and histological features in patients with compensated hepatitis C virus (HCV)-related cirrhosis, we have conducted a randomized, controlled trial of IFN therapy versus observation. Eight centers included a total of 99 pati